SCHEMBL31086993

SCHEMBL31086993

CCCCOc1ccc(S(=O)(=O)NC(CC(C)C)C(=O)NO)cc1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 7/20 0.57
MMP1 P03956 7/20 0.57
MMP2 P08253 2/20 0.57
MMP14 P50281 2/20 0.57
ADAMTS4 O75173 1/20 0.57
ADAMTS5 Q9UNA0 1/20 0.57
MMP3 P08254 4/20 0.55
ADAM17 P78536 5/20 0.52
MMP9 P14780 5/20 0.52
CTDSP1 Q9GZU7 1/20 0.51
KCNA5 P22460 2/20 0.50
MMP7 P09237 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ADAM10 O14672 1/20 0.49
MMP8 P22894 1/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2512625 0.92 MMP13 (0.51) MMP13MMP1MMP2MMP14ADAMTS4
SCHEMBL2512623 0.92 MMP13 (0.51) MMP13MMP1MMP2MMP14ADAMTS4
SCHEMBL2513415 0.91 MMP13 (0.50) MMP13MMP1MMP2MMP14ADAMTS4
SCHEMBL2513418 0.91 MMP13 (0.50) MMP13MMP1MMP2MMP14ADAMTS4
SCHEMBL7411093 0.90 MMP13 (0.60) MMP13MMP1MMP2MMP14ADAMTS4
SCHEMBL2513175 0.90 MMP13 (0.49) MMP13MMP1MMP2MMP14ADAMTS4
SCHEMBL2513178 0.90 MMP13 (0.49) MMP13MMP1MMP2MMP14ADAMTS4
SCHEMBL31086930 0.89 MMP13 (0.65) MMP13MMP1MMP2MMP14ADAMTS4
SCHEMBL31086921 0.89 MMP13 (0.65) MMP13MMP1MMP2MMP14ADAMTS4
SCHEMBL7464064 0.88 MMP13 (0.57) MMP13MMP1MMP2MMP14ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144730-A1 COMPOSITION FOR SKIN ANTI-AGING, SKIN BRIGHTENING OR SKIN REVERSE-AGING CONTAINING AMIDE-BASED COMPOUND AMOREPACIFIC CORPORATION (KR) 2026-05-28 US claimed
US-20260083715-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING AMIDE-BASED COMPOUND AMOREPACIFIC CORPORATION (KR) 2026-03-26 US claimed
EP-4692062-A1 NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME Amorepacific Corporation (KR) 2026-02-11 EP claimed
WO-2024205303-A1 NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME (주)아모레퍼시픽 2024-10-03 WO claimed
US-20260144730-A1 COMPOSITION FOR SKIN ANTI-AGING, SKIN BRIGHTENING OR SKIN REVERSE-AGING CONTAINING AMIDE-BASED COMPOUND AMOREPACIFIC CORPORATION (KR) 2026-05-28 US disclosed
US-20260083715-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING AMIDE-BASED COMPOUND AMOREPACIFIC CORPORATION (KR) 2026-03-26 US disclosed
EP-4692062-A1 NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME Amorepacific Corporation (KR) 2026-02-11 EP disclosed
WO-2024205303-A1 NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME (주)아모레퍼시픽 2024-10-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260144730-A1 COMPOSITION FOR SKIN ANTI-AGING, SKIN BRIGHTENING OR SKIN REVERSE-AGING CONTAINING AMIDE-BASED COMPOUND TYR, ATG13, ARGLU1 MMP13 67/4885MMP1 531/4885MMP2 694/4885
US-20260083715-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING AMIDE-BASED COMPOUND ARG1, MSR1, TLR1 MMP13 3206/4885MMP1 2517/4885MMP2 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.